Cipla’s Revlimid Settlement Offers Date-Certain US Launch

Deal With Bristol Myers Squibb's Celgene Allows Initial ‘Limited’ Volumes

 
• By David Wallace
  
Handshake
Cipla and Bristol Myers Squibb's Celgene have settled over Revlimid • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business